# Assessment of Glypican 3 as Apredictive Marker in Colorectal Cancer Patients

> **NCT04728139** · NA · UNKNOWN · sponsor: **Assiut University** · enrollment: 90 (estimated)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DIAGNOSTIC_TEST:** glypican 3

## Key facts

- **NCT ID:** NCT04728139
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03
- **Primary completion:** 2024-09
- **Final completion:** 2024-10
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2022-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04728139

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04728139, "Assessment of Glypican 3 as Apredictive Marker in Colorectal Cancer Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04728139. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*